Synthesis and in vitro biological evaluation of novel 2-aminoimidazolone derivatives as anti-tumor agents

Chinese Chemical Letters

Volumn 24, Issue 8, 2013, Pages 727-730

  Xiao, You An ^a,b   Wang, Zhi Qiang ^b,c   Wang, Xue Min ^b   Hui, Yi ^b   Ling, Yong ^b   Wang, Xin Yang ^b   He, Li Qin ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^b NANTONG MEDICAL COLLEGE   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

2 Aminoimidazolone; Anti tumor agents; Cell apoptosis; Cytotoxic activities; Synthesis

Indexed keywords

EID: 84879914724     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2013.05.009     Document Type: Article

References (14)

1. P. Boyle, and B. Levin World Cancer Report 2008 WHO International Agency for Research on Cancer Lyon, France
2. R. Breinbauer, M. Manger, and M. Scheck Natural product guided compound library development Curr. Med. Chem. 9 2002 2129 2145
3. 21 furanoterpene from the Indian marine sponge Hippospongia sp. Chin. Chem. Lett. 11 2000 327 330
4. A. Aiello, E. Fattorusso, and C. Imperatore Zorrimidazolone, a bioactive alkaloid from the non-indigenous Mediterranean Stolidobranch Polyandrocarpa zorritensis Mar. Drugs 9 2011 1157 1165
5. A.D. Rohan, W. Aalbersberg, and S. Meo The isolation and synthesis of polyandrocarpamines A and B. Two new 2-aminoimidazolone compounds from the Fijian ascidian Polyandrocarpa sp. Tetahedron 58 2002 3263
6. A.D. Rohan, S.B. Paul, and E.N. Juliette A microwave-assisted stereoselective synthesis of polyandrocarpamines A and B Tetrahedron Lett. 50 2009 880 882
7. M.F. Pilar, M. Pedro, and A.S. Miguel A convergent approach to midpacamide and dispacamide pyrrole-imidazole marine alkaloids Tetrahedron Lett. 42 2001 851 854
8. J.C. Boehm, J.G. Gleason, and I. Pendrak Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist Leucettamine A and related analogues J. Med. Chem. 36 1993 3333 3340
9. A.D. Rohan, H. Andreas, and O. Asiah A class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing J. Med. Chem. 54 2011 4172 4186
10. M. Debdab, S. Renault, and O. Lozach Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors Eur. J. Med. Chem. 45 2010 805 810
11. B.K. Park, N.R. Kitteringham, and P.M. O'Neill Metabolism of fluorine-containing drugs Annu. Rev. Pharmacool. Toxicol. 41 2001 443 470
12. K.L. Kirk, and R. Filler Recent advances in the biomedicinal chemistry of fluorine-containing compounds I. Ojima, J.R. McCarthy, T. Welch, Biomedical Frontiers of Fluorine Chemistry 1996 ACS Symposium Series No. 639, American Chemical Society Washington, DC 1 24
13. 3-catalysed synthesis of 2-aryl quinazolin-4(3H)-ones and 5-aryl pyrazolo [4,3-d] pyrimidin-7(6H)-ones and their evaluation as potential anticancer agents Bioorg. Med. Chem. Lett. 22 2012 5063 5066
14. Y. Liu, W. Zhong, and S. Li Syntheses and studies of hydantoin derivatives as potential anti-tuberculosis inhibitors Chin. Chem. Lett. 23 2012 133 136